2016/17 P 1 P 8 P13 P18 P23 P28 7 P33 P41 15 P48 P65 GC-MS/MSLC-MS/MS
2016/17 2016 48 1.00 AH3 75.4% HI AH1pdm09 B AH3 D151GD151N HA AH1pdm09 AH3 B 5000 500 2016/17-1 -
2016 2017 78 24 well MDCKLLC-MK2HEp-2HeLa RD-18sVero Caco-2 2016/17 1) 0.75% HI A(H1N1)pdm09 B 3 A(H3N2) 2 QIAamp Viral RNA Mini Kit QIAGEN RNA OneStep RT-PCR Kit QIAGEN NA RT-PCR PCR QIAQuick PCR Purification Kit QIAGEN DNA BigDye Terminator v3.1 Cycle Sequencing Kit Applied BiosystemsBigDye XTerminator KitApplied BiosystemsApplied Biosystems 3500 MEGA6 NJ AH1pdm09 NA H275Y 1) AH3 NA E119VD151VQ226HG248RK249ER292KN294S 1,3,4) B NA R150KD197ED197NI221TN294SG407S 1) 2016/17 2016 48 1.00 2017 5 30.00 5) 6) - 2 -
80 70 60 50 40 30 20 10 0 2016/17 76 65 AH1pdm09 1.5%AH3 49 75.4%B 7.7% B 10 15.4% B Victoria 15.4% A H1pdm09 1.5% B Yamagata 7.7% A H3 75.4% - 3 -
2016/17 9 8 7 6 5 4 3 2 1 0 B Victria B Yamagata AH3 AH1pdm09 2016/17 AH3 2 AH1pdm09 2017 2 B B 1:2 1:1.6 7)B AH3 D151GD151N NA HI AH3 49 A/Hong Kong/4801/2014 NA D151GD151N HI 10 640 10 HA 3C.2a 10% 7) - 4 -
3C.2a 3C.2 3C.3a 3C.3 AH3 HA AH1pdm09 B 10 HI AH1pdm09 2015 2017/18 WHO A/Michigan/45/2015 8) A/California/7/2009 AH3 2014/15 2014/15 A/Hong Kong/4801/2014 A/Switzerland/9715293 B - 5 -
A(H1N1)pdm09 NA A(H3N2) NA B NA 16-2016 2015/16-6 -
70% 1) :, 3, 26 9 http://www.nih.go.jp/niid/images/lab-manual/influenza2014.pdf 2017 7 20 2),,,:,60,61-66,2009 3) Monto,A.S.,McKimm-Berschkin,et al.:antimicrobial Agents and Chemotherapy.,50,2395-2402,2006 4) Sheu,T.G.,Deyde,et al.:antimicrobial Agents and Chmotherapy.,52,3284-3292,2008. 5) : http://www.city.niigata.lg.jp/iryo/kenko/yobou_kansen/400kansen/0403shuho_1.htm l2017 7 20 6) ; http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/kekkaku-ka nsenshou01/houdou.html2017 7 20 7),;2016/17 29 6 19 https://www.niid.go.jp/niid/images/idsc/disease/influ/fludoco1617.pdf 2017 7 31 8) WHO;Recommended composition of influenza virus vaccines for use in the 2017-2018 northern hemisphere influenza season http://www.who.int/influenza/vaccines/virus/recommendations/201703_recommenda tion.pdf?ua=1 2017 7 31-7 -
9 28.6% 5~7 56 2 100g MPN3 56 28 MPN 1 12 2 1 28 6 29 2 4 AD 72 4 2 9 2 1 1 1g No.2OXOID OXOIDOXOID - 8 -
9ml 42 22 24 OXOID CCDA OXOID 42 4648 OXOID C.jejuniC.coli 10g 20 7 14 28 56 43 C.jejuniC.coli McFarland 1 1ml 150g High Dose McFarland 1 1000 1ml 150g (Low Dose) 25g 20 0 7 14 28 56 43 25g 100ml 1 10 100 1mL 9mL 3 100g MPN 3 1 2 AD 2 1 2 6 2 9 9 28.6%7 10 1 14.3% 7 C9 CD10 C1 C 2 C A B 6.9%5 /72-9 -
100.0% 80.0% 60.0% 40.0% 20.0% 0.0% 14.3% 28.6% 14.3% 14.3% 0.0% 0.0% 0.0%0.0% 0.0% 100.0% 80.0% 60.0% 40.0% 20.0% 0.0% 11.1% 0.0% 0.0% 0.0% 0.0% 33.3% 11.1% 0.0% A-1 A-2 B-1 B-2 C-1 C-2 D-1 D-2 1 7 56 3 2 High dose Low Dose High Dose 56 Low Dose 28 MPN 56-10 -
4 4 9 5~7 6.9%5 /72 27 2 H25 62.5%8 5 H27 20.0%5 1 H25 28.6%8/28 H26 10.1%(17/168 ) H26 28 2 56 100-11 -
- 12 -
- 13 -
Copy 7000 6000 5000 4000 3000 2000 1000 0 G 3 7-14 -
Copy 7000 6000 5000 4000 3000 2000 1000 0 G 3 7-15 -
- 16 -
- 17 -
LC/MS/MS (1) LC/MS 1mg/ml (2) 2 1 (3) (4) 1-1 1-2 1-3 Waters Xevo TQD 1-1 LC Waters:HSS C181.8µm 2.1 100mm 40 10 2.0µL A B ml/min 0.4 6.5-18 -
Time(min) 0 1.5 2.0 3.0 A 99 99 5 99 B 1 1 95 1 1-2 MS ESI+ 1.5kV 1200 L/hr 150 1-3 MRM m/z CV(V) CE(eV) 72.1 55.0 26 8 44.1 26 12 13 C3 75.1 58.1 26 8 45.1 26 12 (1) 1.0 g 100mL 5mL SepPak AC-2 400mg 3 C18(1g)tC18(900mg)HLB(500mg Waters C18 82% 2 60% 40% 1 15mL 5mL 15mL30mL45mL 2 C18 5mL - 19-100 50 0 100 50 0 82 BL 60 63 44 43 45 C18 C18 HLB 82 BL 44 45 45 15mL 30mL 45mL
10 5mL 10mL 3 C18 15mL 100 50 0 BL 82 83 73 75 44 45 36 39 5mL 10mL 5mL 10mL 40 (2) 4 13 C 2 40 95 250 ppb 2 1000 ppb (3) 2 5 50 ng/g 1000 ng/g 3 54 41-20 -
30 2600 ng/g 10120 4 2 (ng/g) % % % 500 95 42 40 800 95 35 30 800 95 76 69 1000 111 69 72 50 101 78 81 ppb 2 ~ 1000 2 ~ 50 ng/g % 3 % % % 1000 % % 50 101 3.3 3.9 81 5.8 4.6 1000 111 4.4 7.2 72 5.7 9.0 4 8 8 27 57 5 5 43 56 3 7 54 81 3 3 51 69 6 10 18 77 2 3 34 71 3 3 18 43 3 3 17 42 2 10 8 10 66 126 10 LC/MS/MS - 21 -
40-22 -
8 348 76 95 25 3 26-1 3-2 (1) GC 257 LC 91 348 (2) 8 3 10%8.4(4.2) 10%(27.6) 18.034.1 0Trace0.83 % (3) -2 (4) 3 0.1mg/kg (5) 1-1 1-2 GC 7890B MS 7000CAgilent LC ACQUITY UPLC-H Class MS Xevo TQD Waters - 23 -
1-1 GC/MS/MS VF5MS 0.25mm 30m 0.25µm 70(2 ) 25/ 150 3/ 200 8/ 300(4 ) 250 280 2 µl EI 70eV 1-2 LC/MS/MS Waters:HSS C18 1.8µm 2.1 100 mm 45 A5mmol/L B5mmol/L 0.4 ml/min 2 µl 0 0.5 1.5 2.5 3.5 9 15 A 85 60 60 50 45 5 85 B 15 40 40 50 55 95 15 150 1000L/hr550 ESI 0.75V (1) -2 A B 10 ml PSA ODSSep-Pak Vac 1g 2g Waters GC/NH2InertSep GC/NH2(500mg/500mg/6mL GL ) 2 GC/MS/MS LC/MS/MS GC/MS/MS PEG300 50ppm GC PEG300 100ppm (2) GC - 24 -
50200 RSD% 30 2 2-12-3 2 GC LC 257 91 348 50 50 200 200 10% A 248 83 331 16 332 0 246 86 332 15 333 0 10% 244 81 325 19 325 4 A 245 76 321 24 322 2 240 82 322 22 324 2 201 55 256 89 259 0 A 184 53 237 94 248 6 67 16 83 265 83 0 209 55 264 69 267 12 B 213 54 267 70 273 5 217 51 268 76 271 1-25 -
200 50 ODS 50 S/N 10 A B 3-2 8 348 76 264 95 332-26 -
- 27 -
11 3 11 3 2 (1) 13 1-3 (2) (3) HLB200 mg 6 ccprime-hlb 200 mg 6 cc Waters (4) 5.0g 3 0.5ppm 10 0.1ppm (5) 100ppm 5ppm 2:8 (6) 1-1 1-2 1-3 Waters Xevo TQD LC ACQUITY UPLC-H Class 1-1 LC Waters:BEH C18 1.7µm 2.1 100 mm 50 A0.05 B 0.4 ml/min 10 µl Posi Time(min) 0 1.0 3.5 8.0 10.0 13.5 A 92 92 80 30 1 92 B 8 8 20 70 99 8 1-2 MS ESI(+) 0.75 kv (+) 1200L/hr 650-28 -
33L/hr 150 1-3 MRM (m/z) CVV CE(eV) RT(min) 1 Oxytetracycline 426.1 18 461.1 34 444.1 18 5.12 2 Chlortetracycline 479.1 444.1 18 34 462.1 18 6.20 3 Tetracycline 445.1 410.1 18 30 427.1 14 5.02 4 Oxolinic_acid 262.1 216.1 30 32 244.1 19 6.61 5 Ormetoprim 275.1 259.2 40 28 5.04 6 Sulfaquinoxaline 301.1 92.2 30 32 156.1 16 6.70 7 Sulfadimidine 279.1 92.0 30 35 124.1 20 4.61 8 Sulfamonomethoxine 311.1 92.0 32 36 156.0 20 6.49 9 Sulfamerazine 265.1 92.0 25 35 156.0 15 3.50 10 Sulfamonomethoxine 92.0 35 281.0 35 156.0 22 5.17 11 Trimethoprim 291.3 123.0 30 40 230.2 30 4.38 12 Pyrimethamine 249.2 177.1 40 40 233.1 30 6.52 13 Flubendazole 314.1 123.0 35 45 282.0 25 8.30 RT 10mL 5.0 HLB PRiME HLB 0.2%(1:1:3) 50mL 10 ml 3,000rpm 10min 10 ml 2 100 ml 30mL20mL 40 0.4 ml 1.6 ml 1 2.0 ml ( 5 5 ml (9:15 ml 10 ml Filter 0.2 µm LC/MS/MS - 29 -
(1) (2) HLB HLB N4 2 10 70 2 20 3 10 PRiME-HLB HLB 70120RSD10 HLB PRiME-HLB 0.5 0.25N2 20 10 3 HLB PRiME -HLB (3) LC - 30 -
2 HLB (ppm) (ppm) 0.5g 10mL 10 20 RSD RSD Oxytetracycline 0.5 106 9.4 71 8.8 Chlortetracycline 1 0.5 71 15.8 45 11.1 Tetracycline 0.5 110 5.2 93 5.8 Oxolinic_acid 0.02 0.1 92 2.6 70 6.1 Ormetoprim 0.05 0.1 104 5.8 97 5.6 Sulfaquinoxaline --- 0.1 91 4.4 100 6.8 Sulfadimidine 0.1 0.1 69 5.6 82 6.6 Sulfamonomethoxine 0.05 0.1 64 3.4 81 7.2 Sulfamerazine 0.1 0.1 58 1.8 85 3.8 Sulfadimethoxine 0.1 0.1 70 4.1 72 2.9 Trimethoprim 0.1 0.1 93 4.2 97 6.4 Pyrimethamine 0.05 0.1 91 6.5 90 3.6 Flubendazole 0.3 0.1 88 10.4 69 10.5 3 PRiME-HLB 0.5g 10mL 20 0.25g 5mL 10 (ppm) (ppm) RSD RSD Oxytetracycline 0.5 95 5.0 90 5.9 Chlortetracycline 1 0.5 88 2.1 83 4.1 Tetracycline 0.5 104 6.8 106 0.93 Oxolinic_acid 0.02 0.1 103 8.4 100 2.6 Ormetoprim 0.05 0.1 101 5.5 107 0.58 Sulfaquinoxaline --- 0.1 106 0.46 96 5.4 Sulfadimidine 0.1 0.1 82 0.89 72 1.7 Sulfamonomethoxine 0.05 0.1 75 10.0 71 4.7 Sulfamerazine 0.1 0.1 77 5.2 74 0.33 Sulfadimethoxine 0.1 0.1 81 3.5 70 0.35-31 -
Trimethoprim 0.1 0.1 96 2.0 103 2.6 Pyrimethamine 0.05 0.1 106 1.1 103 6.2 Flubendazole 0.3 0.1 94 3.1 93 0.16 13 HLB PRiME-HLB 1 27 40-32 -
- 33 -
.1. - 34 -
100cm 2,12.5cm8cm100ml 50ml 200rpm 10min 0.2m ICS-1100 g/cm 2 / (g/cm 2 /day) 0.350 0.300 0.250 0.200 0.150 0.100 0.050 0.000 11 12 12-1 1-2 2-3. - 35 -
mg/m 2 NaCl 600 500 400 300 200 100 0 0 2 4 6 8 10 12 14 16. 28 E=1/2 mv 2 m: v:e 2 2-36 -
(m/s)2 (g/cm2/day) 18000 16000 14000 12000 10000 8000 6000 4000 2000 0 ^2 11 12 12-1 1-2 2-3 0.350 0.300 0.250 0.200 0.150 0.100 0.050 0.000 1/2 (mg/m 2 )NaCl - 37 -
1/2 482m 181 9cm cm - 38 -
() mg/m 2 NaCl 500 450 400 350 300 250 200 150 100 50 0 0 2 4 6 8 10 12 14 16. 27-39 -. 26 28 mg/m 2 NaCl
mg/m 2 (m/s) 2 NaCl - 40 -
1960 1970 12 2 28 28 2-11-2 37.94 139.08 14m 4m 1.2km 1.2km 1.3km 1km 2151-1 37.88 138.99 15m 15m 1.7km - 41 -
28 4 29 3 US-330 314cm 2 2 2 1) 1 1 ph EC SO4 2 NO3 Cl NH4 Na K Ca 2 Mg 2 ph EC 10 1928 ph EC 1 28 ph 4.86 4.68 ph 5.6 EC 3.91mS/m 3.66mS/m phec ph EC [ms/m] 5.60 5.20 4.80 4.40 4.00 H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 10.0 8.0 6.0 4.0 2.0 0.0 H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 1 ph EC - 42 -
5 2327 28 2 28 5 Na Cl nss-so4 2 nssnon-sea salt NO3 [%] 100 80 60 40 20 0 Na+ Cl- Mg2+ ss-so42- K+ nss-so42- ss-ca2+ NO3- nss-ca2+ NH4+ H28 5 H28 5 H+ 2 R1R2 28 R1 R2 3 R10 86% R1 R2 R1 [%] 40 30 20 10 0-10 -20-30 -40 1 10 100 1000 10000 Cations + Anions [μeq/l] R2 [%] 30 20 10 0-10 -20-30 0.1 1 10 100 EC [ms/m] 3 R1 R2 EC 5 2327 28 4 EC Na K - 43 -
NO3 nss-so4 2 NH4 9 3) 6 ph EC [mm] 450 400 350 300 250 200 150 100 50 0 4 5 6 7 8 9 10 11 12 1 2 3 [ms/m] 14 12 10 8 6 4 2 0 4 5 6 7 8 9 10 11 12 1 2 3 Na + K + [μmol/l] 800 700 600 500 400 300 200 100 0 4 5 6 7 8 9 10 11 12 1 2 3 [μmol/l] 16 14 12 10 8 6 4 2 0 4 5 6 7 8 9 10 11 12 1 2 3 NO 3 - nss-so 4 2- [μmol/l] 80 70 60 50 40 30 20 10 0 4 5 6 7 8 9 10 11 12 1 2 3 [μmol/l] 50 40 30 20 10 0 4 5 6 7 8 9 10 11 12 1 2 3 NH 4 + ph 100 6.00 [μmol/l] 80 60 40 20 ph unit 5.50 5.00 4.50 0 4 5 6 7 8 9 10 11 12 1 2 3 4.00 4 5 6 7 8 9 10 11 12 1 2 3 H28 H28 H23H27 H23H27 H23H27-44 -
4 2 5 5 5 24 28 6 7 EC Na + [mm] 400 300 200 100 y = 0.8778x + 15.288 R² = 0.84 [ms/m] 12 10 8 6 4 2 y = 1.0224x - 0.048 R² = 0.9485 [μmol/l] 700 600 500 400 300 200 100 y = 1.0043x - 3.8525 R² = 0.9517 0 0 100 200 300 400 0 0 2 4 6 8 10 12 0 0 100 200 300 400 500 600 700 [mm] [ms/m] [μmol/l] 6 ECNa 1 1 EC Na 11km - 45 -
EC Na Na Cl EC EC nss-so 4 2- NO 3 - NH 4 + 50 40 y = 0.9399x - 1.6103 R² = 0.8842 80 60 y = 0.8704x + 1.6371 R² = 0.8979 100 80 y = 0.7572x + 0.3017 R² = 0.8464 [μmol/l] 30 20 [μmol/l] 40 [μmol/l] 60 40 10 20 20 0 0 10 20 30 40 50 0 0 20 40 60 80 0 0 20 40 60 80 100 [μmol/l] [μmol/l] [μmol/l] ph nss-ca 2+ 5.6 5.4 5.2 5.0 4.8 4.6 4.4 y = 0.701x + 1.2998 R² = 0.5918 [μmol/l] 35 30 25 20 15 10 y = 0.6223x - 0.262 R² = 0.7953 4.2 5 4.0 4.0 4.2 4.4 4.6 4.8 5.0 5.2 5.4 5.6 0 0 5 10 15 20 25 30 35 [μmol/l] 7 nss-so4 2 NO3 NH4 phnss-ca 2 1 1 nss-so4 2 NO3 NH4 ph nss-ca 2 4m 15m ph 28 2-46 -
ph EC Na + Cl EC Na K NO3 nss-so4 2 NH4 9 2 nss-so4 2 NO3 NH4 ph nss-ca 2 2 28 29 1 1) 2 2001https://www.env.go.jp/air/acidrain/man/wet_deposi/index.html 2) EANETTechnical Manual for Wet Deposition Monitoring in East Asia -2010 http://www.eanet.asia/product/manual/techwet.pdf 3) 27 4066-722016 http://www.city.niigata.lg.jp/iryo/shoku/syokuei/shokueishisetsu/eisei_ken/eiken_chousa.files/kenkyukankyo.pdf - 47 -
15 5 14 11 17 21 5 37 22 26 28 2 3 1 28 4 3 2 (1) 28 5 23,24 (2) 1 St- 1 St- 2 St- 3 St- 4 St- 1 St- 2 St- 3 St-3 St-2 St-1 St-1 St-2 St-3 St-4-48 -
(3) 20 ph (4) 2 Shannon 62 110 ASPT ASPT 10 ASPT ASPT ASPT ASPT ASPT =() 29 4 Shannon Shannon Weaver1963 () H - 49 - n N ln n N S N nii 3 (1) 1 2 (a)(b) 3 4 Shannon -1 St- 1 30m 20cm
9 7 6 3 1 28 26 ASPT 5.8 26 3 6 26 15 19 Shannon 1.6-2 St- 2 30m 20cm 9 7 ASPT 8.0 26 5.0 4 2 9 3 Shannon 0.94 28-3 St- 3 40m 30cm 9 7 3 1 ASPT 4.7 6 38 17 26 ASPT Shannon 1.3-4 St- 4 20m 40cm 9 7 2 1 ASPT 4.7 6 ASPT 26 Shannon 1.5-50 -
2 (a) (b) - 51 -
3 4 4 ph 7 SS St- 3 28 1015 DO St- 1St- 2St- 3 St- 4 28 8 11 ASPT St- 2 St- 1 St- 3St- 4 Shannon 26 St- 1 St- 2 St- 3St- 4 BOD75-52 -
2 BOD75 ASPT BOD75% 10 ASPT St- 2 58 4 St- 1St- 3St- 4 5 26 4 BOD75%(mg/l) 5.0 4.0 3.0 2.0 1.0 0.0 BOD75% ASPT H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 0 1 2 3 4 5 6 7 8 9 10 ASPT BOD75%(mg/l) 5.0 4.0 3.0 2.0 1.0 0.0 BOD75% ASPT H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 0 1 2 3 4 5 6 7 8 9 10 ASPT (a) St- 1 (c)st- 3 BOD75%(mg/l) 5.0 4.0 3.0 2.0 1.0 0.0 BOD75% ASPT H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 0 1 2 3 4 5 6 7 8 9 10 ASPT BOD75%(mg/l) 5.0 4.0 3.0 2.0 1.0 0.0 BOD75% ASPT H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 0 1 2 3 4 5 6 7 8 9 10 ASPT (b) St- 2 (d)st- 4 2 BOD75% ASPT - 53 -
(2) 5 6 (a)(b) 7 ASPT 8 Shannon 5-1 St- 1 3m 40 29cm/s 34m 9 7 2 1 ASPT 27 4.8 ASPT 27 6.8 Shannon 1.4-2 St- 2 6m 60 18cm/s 8 7 3 ASPT 6.0 ASPT 6.3 27 Shannon 1.5-54 -
6 (a) (b) -3 St- 3 8m 70cm 7 3 1 ASPT 7 27 3.3 ASPT 27 3.3 Shannon 1.3-55 -
7 ASPT 8 8 ph 6.97.4 St- 1 St- 3DO St- 1 St- 1 27 7 ASPT ASPT St- 2 7 ASPT ASPT St- 3 1 ASPT ASPT ASPT ASPT St- - 56 -
1 St- 3 Shannon St- 2 8 Shannon ASPT ASPT 3 St- 1 St- 3 BOD75 St- 1St- 3 10 BOD75 ASPT St- 1 27 St- 2St- 3 ASPT ASPT 4 (1) ASPT St- 2 St- 1 St- 3St- 4 Shannon 28 St- 1St- 3 St- 4 1.5 St- 2 0.94 BOD75% 10-57 -
ASPT St- 2 58 4 St- 1St- 3St- 4 5 26 BOD75%(mg/l) 5.0 4.0 3.0 2.0 1.0 0.0 BOD75% ASPT ASPT H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 0 1 2 3 4 5 6 7 8 9 10 ASPT (a)st- 1 1 (c)st- 3 2 BOD75%(mg/l) 5.0 4.0 3.0 2.0 1.0 0.0 BOD75% ASPT ASPT H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 0 1 2 3 4 5 6 7 8 9 10 ASPT BOD75%(mg/l) 5.0 4.0 3.0 2.0 1.0 0.0 ASPT ASPT H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 0 1 2 3 4 5 6 7 8 9 10 ASPT 1 1.5 2 3 (b)st- 2 3 BOD75% ASPT (2) ASPT ASPT St- 1 St- 3 Shannon 3 St- 2 St- 1St- 3 10 BOD75 ASPT St- 1 27 St- 2St- 3 ASPT ASPT (3) 26-58 -
25-59 -
St- 1-60 -
St- 2 St- 3-61 -
St- 4-62 -
(2) St- 1-63 -
St- 2 St- 3-64 -
12 COD 28 COD 2 COD COD COD 1. 9 22 2 90 12 12 14 18 5 22 50 COD 21 3 24 3 COD COD 27 28 2. No.2 No.16 11 No.3 No1,3,4,6,7 No10,11,16 No1,2,3 ( 1) No11 No16 9 9 No7 B COD 3.0mg/L 8 A 2.0mg/L No.1 No.1 No.4 No.3 No.6 No.7 No.10 No.11-65 -
2.1 COD 9 11 28 COD (75) 1 COD 1 COD75% (mg/l) No1,3,4,6,7 5 No6 No10 No1,2,3 28 No6 No10 2 24 28 5 3. 28 4 6,8,10 5 4 No6,7,10 No2 2 3 0m 3m 1m COD 4. 66
4.1 28 4.1.1 COD COD No6 6 8 4 5 10 3 6 8 No7 6 8 No10 No6 6 8 No2 3 6 8 4 6 8 No2 6 8 2mg/L No6,7 6 6,7,10 3 2mg/L 8 10 6 10 4.1.2 No.6No.7No.10 3 No6 No.6 No.7 4 5 6,8,10 No.10 4,5 6 10 No2 3 4.1.3 4 4 5 6 No.6,7,10 No.2 No.6,7,10 No.2 No6 8,No7 10 10 5,8 No6No7 0.0600.080mg/L 2 No.6,7,10 8 No.2 6 No.6,7,10 No.2 67
COD (mg/l) COD mg/l 68
mg/l 6. 6.1 COD COD No.6,7,10 No.2 20,000 20,000 mg/l 15,000 10,000 5,000 15,000 10,000 5,000 0 0 69
COD COD 12mg/l COD 2mg/l 700015000mg/l COD COD 4 5 10 4 5 10 6 8 COD COD COD 6.2 COD 1.32.2 COD COD COD COD 70
6.3 COD 4 10 COD 6.1 COD 8 6 8 6,8 COD COD 5070 2050 COD 6.4 COD COD 3 1 COD 4 28 4 8 10 COD 1.5mg/l 28 5 4 1.5mg/l COD COD 2528 7. 9 28 9 COD 7 2 COD COD COD COD COD 71
COD COD COD 1) 27 2) 72
COD mg/l mg/l 73
mg/l mg/l 74
a mg/l 75
26 3 26-20 28 11 GC-MS/MSLC-MS/MS 401 248 GC 28
JR1520 JRBRT W427 5 29 10 9502023 2151 1 TEL 025(231)1231 FAX 025(230)5818 e-maileisei.rc@city.niigata.lg.jp - 40 -